Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma
Background/Objectives: Systemic chemotherapy is recommended for all stages of pancreatic ductal adenocarcinoma (PDAC), with a recent shift towards neoadjuvant chemotherapy (NAC) for resectable PDAC. The objective of this study was to compare outcomes of NAC versus AC for early stage resectable PDAC...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2022-12-01
|
| Serier: | Surgery in Practice and Science |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2666262022000778 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
